Gebärmutterhalskrebs-Screening in der Schweiz – aktueller Stand und neue Herausforderungen / Cervical cancer screening in Switzerland - current practice and future challenges
|Published in||Therapeutische Umschau. 2013, vol. 70, no. 4, p. 223-30|
|Abstract||At the beginning of the 20th Century, cervical cancer was the leading cause of death from cancer in women. A marked decline in cervical cancer has been observed since the 1960s, in parallel with the introduction of the Papanicolau (Pap) test as a cytological screening method. Today, Pap smear screening is still the most widely used tool for cervical cancer prevention. Testing for human papillomavirus (HPV) in cervical specimens or a combination of Pap and HPV testing are also now available. In this article we compare current guidelines for cervical cancer screening in Switzerland with those in other European countries. In view of the opportunities offered by HPV testing and, since 2008, HPV vaccination, current guidelines for cervical cancer screening should be updated. Both the choice of screening tests and general organization of cervical cancer screening should be reviewed.|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Groupe Petignat Patrick (933)|
|UNTIET, Sarah et al. Gebärmutterhalskrebs-Screening in der Schweiz – aktueller Stand und neue Herausforderungen / Cervical cancer screening in Switzerland - current practice and future challenges. In: Therapeutische Umschau, 2013, vol. 70, n° 4, p. 223-30. https://archive-ouverte.unige.ch/unige:29948|